hepatocellular-carcinoma

Documents about hepatocellular-carcinoma

• Adjuvant Therapies for Patients With HCC and MVI#868718ClinicalTrials.gov
• Different Genetic Features Associated With Hepatic Carcinogenesis#869651ClinicalTrials.gov
• Follow up After TACE by Elastography and Color Doppler.#883861ClinicalTrials.gov
• LifePearl-Doxo Pharmacokinetic (PK) Study#893022ClinicalTrials.gov
• Predictors of Sorafenib Response in HCC#909578ClinicalTrials.gov
• A Retrospective Review of Malignant Liver Tumors#807480ClinicalTrials.gov
• Oncolytic virus therapy for hepatocellular carcinoma: A bibliometric analysis of research landscapes, hotspots, and clinical transformation trends from 2000 to mid-2025#123338Europe PMC
• Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.#843440ClinicalTrials.gov
• Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)#848024ClinicalTrials.gov
• Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC#857850ClinicalTrials.gov
• Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC#860170ClinicalTrials.gov
• Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy#877591ClinicalTrials.gov
• Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma#892478ClinicalTrials.gov
• Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant#897182ClinicalTrials.gov
• Volatile Organic Compounds for the Assessment of Liver Disease#862782ClinicalTrials.gov
• Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer#279514ClinicalTrials.gov
• Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)#234443ClinicalTrials.gov
• A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)#356478ClinicalTrials.gov
• Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma#803526ClinicalTrials.gov
• A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer#842478ClinicalTrials.gov
• Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma#880685ClinicalTrials.gov
• Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery#899854ClinicalTrials.gov
• Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)#904000ClinicalTrials.gov
• The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study#911941ClinicalTrials.gov
• Retrospective Clinical Validation of HepatoPredict#850431ClinicalTrials.gov
• Blood protein biomarkers in hepatocellular carcinoma: progress and challenges.#151450NCBI PubMed Central
• Immunogenicity remodeling in hepatocellular carcinoma: mechanisms and translational strategies.#358303NCBI PubMed Central
• Improving the Use of Immunotherapy to Treat Liver Cancer#471451ClinicalTrials.gov
• ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture#807213ClinicalTrials.gov
• A Study of PTS100 in Primary HCC Patients#832534ClinicalTrials.gov
• Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma#848855ClinicalTrials.gov
• Treatment of Intermediate-stage Hepatocellular Carcinoma#875005ClinicalTrials.gov
• Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT#899427ClinicalTrials.gov
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)#803585ClinicalTrials.gov
• Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma#853776ClinicalTrials.gov
• Additional file 2 of Effect of hepatic arterial dexamethasone administration on long-term survival among hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization#402217Figshare
• Additional file 1 of Effect of hepatic arterial dexamethasone administration on long-term survival among hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization#402218Figshare
• A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma#813547ClinicalTrials.gov
• Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib#867757ClinicalTrials.gov
• Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT#891129ClinicalTrials.gov
• Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery#810122ClinicalTrials.gov
• Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L#141111ClinicalTrials.gov
• MicroRNA-146a Protects against Hepatocellular Carcinoma through Suppression of CCL5.#154422NCBI PubMed Central
• Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation#226145ClinicalTrials.gov
• The Combination Effect of Statin Plus Metformin on Relapse-free#245469ClinicalTrials.gov
• Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC#249593ClinicalTrials.gov
• Biomimetic Polymer-Based Nanomaterials for Immune-Responsive Hepatocellular Carcinoma Therapy.#301624NCBI PubMed Central
• Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion#382229HAL (France)
• Trial Watch: Immunotherapeutic strategies on the horizon for hepatocellular carcinoma#409555ScholarBank@NUS
• Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment#818518HAL (France)